Nano-drug co-delivery system of natural active ingredients and chemotherapy drugs for cancer treatment: a review

References

• Abbasi A, Hajialyani M, Hosseinzadeh L, et al. (2020). Evaluation of the cytotoxic and apoptogenic effects of cinnamaldehyde on U87MG cells alone and in combination with doxorubicin. Res Pharm Sci 15:26–35.
   PubMed Web of Science ®Google Scholar
• Abd Elwakil MM, Mabrouk MT, Helmy MW, et al. (2018). Inhalable lactoferrin-chondroitin nanocomposites for combined delivery of doxorubicin and ellagic acid to lung carcinoma. Nanomedicine (Lond) 13:2015–35.
   PubMed Web of Science ®Google Scholar
• Abedi F, Davaran S, Hekmati M, et al. (2021). An improved method in fabrication of smart dual-responsive nanogels for controlled release of doxorubicin and curcumin in HT-29 colon cancer cells. J Nanobiotechnology 19:18.
   PubMed Web of Science ®Google Scholar
• Ali N, Rashid S, Nafees S, et al. (2014). Beneficial effects of chrysin against Methotrexate-induced hepatotoxicity via attenuation of oxidative stress and apoptosis. Mol Cell Biochem 385:215–23.
   PubMed Web of Science ®Google Scholar
• Amjadi S, Hamishehkar H, Ghorbani M. (2019). A novel smart PEGylated gelatin nanoparticle for co-delivery of doxorubicin and betanin: a strategy for enhancing the therapeutic efficacy of chemotherapy. Mater Sci Eng C Mater Biol Appl 97:833–41.
   PubMed Web of Science ®Google Scholar
• Anbazhagan R, Muthusamy G, Krishnamoorthi R, et al. (2021). PAMAM G4.5 dendrimers for targeted delivery of ferulic acid and paclitaxel to overcome P-glycoprotein-mediated multidrug resistance. Biotechnol Bioeng 118:1213–23.
   PubMed Web of Science ®Google Scholar
• Anwar DM, Khattab SN, Helmy MW, et al. (2018). Lactobionic/folate dual-targeted amphiphilic maltodextrin-based micelles for targeted codelivery of sulfasalazine and resveratrol to hepatocellular carcinoma. Bioconjug Chem 29:3026–41.
   PubMed Web of Science ®Google Scholar
• Arranja AG, Pathak V, Lammers T, et al. (2017). Tumor-targeted nanomedicines for cancer theranostics. Pharmacol Res 115:87–95.
   PubMed Web of Science ®Google Scholar
• Baek JS, Cho CW. (2017). A multifunctional lipid nanoparticle for co-delivery of paclitaxel and curcumin for targeted delivery and enhanced cytotoxicity in multidrug resistant breast cancer cells. Oncotarget 8:30369–82.
   PubMedGoogle Scholar
• Baghbani F, Moztarzadeh F. (2017). Bypassing multidrug resistant ovarian cancer using ultrasound responsive doxorubicin/curcumin co-deliver alginate nanodroplets. Colloids Surf B Biointerfaces 153:132–40.
   PubMed Web of Science ®Google Scholar
• Bian Y, Guo D. (2020). Targeted therapy for hepatocellular carcinoma: co-delivery of sorafenib and curcumin using lactosylated pH-responsive nanoparticles. Drug Des Devel Ther 14:647–59.
   PubMed Web of Science ®Google Scholar
• Borges GSM, Silva JO, Fernandes RS, et al. (2019). Sclareol is a potent enhancer of doxorubicin: evaluation of the free combination and co-loaded nanostructured lipid carriers against breast cancer. Life Sci 232:116678.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. (2018). Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68:394–424.
   PubMed Web of Science ®Google Scholar
• Buhrmann C, Shayan P, Kraehe P, et al. (2015). Resveratrol induces chemosensitization to 5-fluorouracil through up-regulation of intercellular junctions, epithelial-to-mesenchymal transition and apoptosis in colorectal cancer. Biochem Pharmacol 98:51–68.
   PubMed Web of Science ®Google Scholar
• Bukowski K, Kciuk M, Kontek R. (2020). Mechanisms of multidrug resistance in cancer chemotherapy. Int J Mol Sci 21:3233.
   PubMed Web of Science ®Google Scholar
• Cai FY, Yao XM, Jing M, et al. (2020). Enhanced antitumour efficacy of functionalized doxorubicin plus schisandrin B co-delivery liposomes via inhibiting epithelial-mesenchymal transition. J Liposome Res 31:113–129.
   PubMed Web of Science ®Google Scholar
• Cao C, Wang Q, Liu Y. (2019a). Lung cancer combination therapy: doxorubicin and beta-elemene co-loaded, pH-sensitive nanostructured lipid carriers. Drug Des Devel Ther 13:1087–98.
   PubMed Web of Science ®Google Scholar
• Cao M, Long M, Chen Q, et al. (2019b). Development of beta-elemene and cisplatin co-loaded liposomes for effective lung cancer therapy and evaluation in patient-derived tumor xenografts. Pharm Res 36:121.
   PubMed Web of Science ®Google Scholar
• Cao XF, Meng LH, Liu Z, et al. (2018). Research progress in reversing multidrug resistance of tumor by nanocarrier-mediated combined administration. China Pharmacy 29:716–20.
   Google Scholar
• Chavda VP, Patel AB, Mistry KJ, et al. (2022). Nano-drug delivery systems entrapping natural bioactive compounds for cancer: recent progress and future challenges. Front Oncol 12:867655.
   PubMed Web of Science ®Google Scholar
• Chen F, Huang G. (2018). Preparation and immunological activity of polysaccharides and their derivatives. Int J Biol Macromol 112:211–6.
   PubMed Web of Science ®Google Scholar
• Chen F, Zhao Y, Pan Y, et al. (2015). Synergistically enhanced therapeutic effect of a carrier-free HCPT/DOX nanodrug on breast cancer cells through improved cellular drug accumulation. Mol Pharm 12:2237–44.
   PubMed Web of Science ®Google Scholar
• Chen HM, Lai ZQ, Liao HJ, et al. (2018). Synergistic antitumor effect of brusatol combined with cisplatin on colorectal cancer cells. Int J Mol Med 41:1447–54.
   PubMed Web of Science ®Google Scholar
• Chen S, Liang Q, Liu E, et al. (2017). Curcumin/sunitinib co-loaded BSA-stabilized SPIOs for synergistic combination therapy for breast cancer. J Mater Chem B 5:4060–72.
   PubMed Web of Science ®Google Scholar
• Chen S, Song Z, Feng R. (2020a). Recent development of copolymeric nano-drug delivery system for paclitaxel. Anticancer Agents Med Chem 20:2169–89.
   PubMed Web of Science ®Google Scholar
• Chen X, Niu S, Bremner DH, et al. (2020b). Co-delivery of doxorubicin and oleanolic acid by triple-sensitive nanocomposite based on chitosan for effective promoting tumor apoptosis. Carbohydr Polym 247:116672.
   PubMed Web of Science ®Google Scholar
• Chen X, Peng X, Luo Y, et al. (2019). Quercetin protects cardiomyocytes against doxorubicin-induced toxicity by suppressing oxidative stress and improving mitochondrial function via 14-3-3gamma. Toxicol Mech Methods 29:344–54.
   PubMed Web of Science ®Google Scholar
• Chen Y, Zheng XL, Fang DL, et al. (2014). Dual agent loaded PLGA nanoparticles enhanced antitumor activity in a multidrug-resistant breast tumor xenograft model. Int J Mol Sci 15:2761–72.
   PubMed Web of Science ®Google Scholar
• Cheng C, Sui B, Wang M, et al. (2020). Carrier-free nanoassembly of curcumin-erlotinib conjugate for cancer targeted therapy. Adv Healthc Mater 9:e2001128.
   PubMed Web of Science ®Google Scholar
• Cheng T, Liu J, Ren J, et al. (2016). Green tea catechin-based complex micelles combined with doxorubicin to overcome cardiotoxicity and multidrug resistance. Theranostics 6:1277–92.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Zhao P, Wu S, et al. (2018). Cisplatin and curcumin co-loaded nano-liposomes for the treatment of hepatocellular carcinoma. Int J Pharm 545:261–73.
   PubMed Web of Science ®Google Scholar
• Choi JY, Ramasamy T, Kim SY, et al. (2016). PEGylated lipid bilayer-supported mesoporous silica nanoparticle composite for synergistic co-delivery of axitinib and celastrol in multi-targeted cancer therapy. Acta Biomater 39:94–105.
   PubMed Web of Science ®Google Scholar
• Chu PY, Tsai SC, Ko HY, et al. (2019). Co-delivery of natural compounds with a dual-targeted nanoparticle delivery system for improving synergistic therapy in an orthotopic tumor model. ACS Appl Mater Interfaces 11:23880–92.
   PubMed Web of Science ®Google Scholar
• Chung SS, Dutta P, Austin D, et al. (2018). Combination of resveratrol and 5-flurouracil enhanced anti-telomerase activity and apoptosis by inhibiting STAT3 and Akt signaling pathways in human colorectal cancer cells. Oncotarget 9:32943–57.
   PubMedGoogle Scholar
• Coelho AR, Martins TR, Couto R, et al. (2017). Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts. Biochim Biophys Acta Mol Basis Dis 1863:2904–23.
   PubMed Web of Science ®Google Scholar
• Cosco D, Paolino D, Maiuolo J, et al. (2015). Ultradeformable liposomes as multidrug carrier of resveratrol and 5-fluorouracil for their topical delivery. Int J Pharm 489:1–10.
   PubMed Web of Science ®Google Scholar
• Cui T, Zhang S, Sun H. (2017). Co-delivery of doxorubicin and pH-sensitive curcumin prodrug by transferrin-targeted nanoparticles for breast cancer treatment. Oncol Rep 37:1253–60.
   PubMed Web of Science ®Google Scholar
• Cui Y, Zhang M, Zeng F, et al. (2016). Dual-targeting magnetic PLGA nanoparticles for codelivery of paclitaxel and curcumin for brain tumor therapy. ACS Appl Mater Interfaces 8:32159–69.
   PubMed Web of Science ®Google Scholar
• Dai H, Cheng Z, Zhang T, et al. (2022). Boron difluoride formazanate dye for high-efficiency NIR-II fluorescence imaging-guided cancer photothermal therapy. Chin Chem Lett 33:2501–6.
   Web of Science ®Google Scholar
• Dang YP, Yuan XY, Tian R, et al. (2015). Curcumin improves the paclitaxel-induced apoptosis of HPV-positive human cervical cancer cells via the NF-kappaB-p53-caspase-3 pathway. Exp Ther Med 9:1470–6.
   PubMed Web of Science ®Google Scholar
• Davaran S, Fazeli H, Ghamkhari A, et al. (2018). Synthesis and characterization of novel P(HEMA-LA-MADQUAT) micelles for co-delivery of methotrexate and chrysin in combination cancer chemotherapy. J Biomater Sci Polym Ed 29:1265–86.
   PubMed Web of Science ®Google Scholar
• Deb A, Andrews NG, Raghavan V. (2018). Natural polymer functionalized graphene oxide for co-delivery of anticancer drugs: in-vitro and in-vivo. Int J Biol Macromol 113:515–25.
   PubMed Web of Science ®Google Scholar
• Deng L, Zhu X, Yu Z, et al. (2020). Novel T7-modified pH-responsive targeted nanosystem for co-delivery of docetaxel and curcumin in the treatment of esophageal cancer. Int J Nanomedicine 15:7745–62.
   PubMed Web of Science ®Google Scholar
• Dhanavel S, Nivethaa EAK, Narayanan V, et al. (2017). In vitro cytotoxicity study of dual drug loaded chitosan/palladium nanocomposite towards HT-29 cancer cells. Mater Sci Eng C Mater Biol Appl 75:1399–410.
   PubMed Web of Science ®Google Scholar
• Dong K, Zhao ZZ, Kang J, et al. (2020). Cinnamaldehyde and doxorubicin co-loaded graphene oxide wrapped mesoporous silica nanoparticles for enhanced MCF-7 cell apoptosis. Int J Nanomedicine 15:10285–304.
   PubMed Web of Science ®Google Scholar
• Eftekhari RB, Maghsoudnia N, Samimi S, et al. (2019). Co-delivery nanosystems for cancer treatment: a review. Pharm Nanotechnol 7:90–112.
   PubMedGoogle Scholar
• Fan X, Wang T, Ji Z, et al. (2021). Synergistic combination therapy of lung cancer using lipid-layered cisplatin and oridonin co-encapsulated nanoparticles. Biomed Pharmacother 141:111830.
   PubMed Web of Science ®Google Scholar
• Fang J, Zhang S, Xue X, et al. (2018). Quercetin and doxorubicin co-delivery using mesoporous silica nanoparticles enhance the efficacy of gastric carcinoma chemotherapy. Int J Nanomedicine 13:5113–26.
   PubMed Web of Science ®Google Scholar
• Fang JH, Lai YH, Chiu TL, et al. (2014). Magnetic core-shell nanocapsules with dual-targeting capabilities and co-delivery of multiple drugs to treat brain gliomas. Adv Healthc Mater 3:1250–60.
   PubMed Web of Science ®Google Scholar
• Fang Q, Xu X, Yang L, et al. (2021). Self-assembled 5-fluorouracil-cinnamaldehyde nanodrugs for greatly improved chemotherapy in vivo. J Biomater Appl 36:592–604.
   PubMed Web of Science ®Google Scholar
• Feng Q, Tong R. (2016). Anticancer nanoparticulate polymer-drug conjugate. Bioeng Transl Med 1:277–96.
   PubMed Web of Science ®Google Scholar
• Fu L, Ma X, Liu Y, et al. (2022). Applying nanotechnology to boost cancer immunotherapy by promoting immunogenic cell death. Chin Chem Lett 33:1718–28.
   Web of Science ®Google Scholar
• Gan D, He W, Yin H, et al. (2020). β-elemene enhances cisplatin-induced apoptosis in bladder cancer cells through the ROS-AMPK signaling pathway. Oncol Lett 19:291–300.
   PubMed Web of Science ®Google Scholar
• Gao C, Tang F, Gong G, et al. (2017a). pH-responsive prodrug nanoparticles based on a sodium alginate derivative for selective co-release of doxorubicin and curcumin into tumor cells. Nanoscale 9:12533–42.
   PubMed Web of Science ®Google Scholar
• Gao J, Fan K, Jin Y, et al. (2019). PEGylated lipid bilayer coated mesoporous silica nanoparticles co-delivery of paclitaxel and curcumin leads to increased tumor site drug accumulation and reduced tumor burden. Eur J Pharm Sci 140:105070.
   PubMed Web of Science ®Google Scholar
• Gao J, Ma X, Zhang L, et al. (2020). Self-assembled disulfide bond bearing paclitaxel-camptothecin prodrug nanoparticle for lung cancer therapy. Pharmaceutics 12:1169.
   PubMed Web of Science ®Google Scholar
• Gao X, Yu T, Xu G, et al. (2017b). Enhancing the anti-glioma therapy of doxorubicin by honokiol with biodegradable self-assembling micelles through multiple evaluations. Sci Rep 7:43501.
   PubMed Web of Science ®Google Scholar
• Gao Y, Zhu Y, Xu X, et al. (2021). Surface PEGylated cancer cell membrane-coated nanoparticles for codelivery of curcumin and doxorubicin for the treatment of multidrug resistant esophageal carcinoma. Front Cell Dev Biol 9:688070.
   PubMed Web of Science ®Google Scholar
• Gu J, Fan YQ, Zhang HL, et al. (2018). Resveratrol suppresses doxorubicin-induced cardiotoxicity by disrupting E2F1 mediated autophagy inhibition and apoptosis promotion. Biochem Pharmacol 150:202–13.
   PubMed Web of Science ®Google Scholar
• Guo F, Yu N, Jiao Y, et al. (2021). Star polyester-based folate acid-targeting nanoparticles for doxorubicin and curcumin co-delivery to combat multidrug-resistant breast cancer. Drug Deliv 28:1709–21.
   PubMed Web of Science ®Google Scholar
• Guo H, Zhang Z, Su Z, et al. (2016). Enhanced anti-tumor activity and reduced toxicity by combination andrographolide and bleomycin in ascitic tumor-bearing mice. Eur J Pharmacol 776:52–63.
   PubMed Web of Science ®Google Scholar
• Guo P, Pi C, Zhao S, et al. (2020a). Oral co-delivery nanoemulsion of 5-fluorouracil and curcumin for synergistic effects against liver cancer. Expert Opin Drug Deliv 17:1473–84.
   PubMed Web of Science ®Google Scholar
• Guo W, Song Y, Song W, et al. (2020b). Co-delivery of doxorubicin and curcumin with polypeptide nanocarrier for synergistic lymphoma therapy. Sci Rep 10:7832.
   PubMed Web of Science ®Google Scholar
• Guo X, Zhao Z, Chen D, et al. (2019). Co-delivery of resveratrol and docetaxel via polymeric micelles to improve the treatment of drug-resistant tumors. Asian J Pharm Sci 14:78–85.
   PubMed Web of Science ®Google Scholar
• Han NN, Li X, Tao L, et al. (2018). Doxorubicin and rhein loaded nanomicelles attenuates multidrug resistance in human ovarian cancer. Biochem Biophys Res Commun 498:178–85.
   PubMed Web of Science ®Google Scholar
• He W, Hu X, Jiang W, et al. (2017). Rational design of a new self-codelivery system from redox-sensitive camptothecin-cytarabine conjugate assembly for effectively synergistic anticancer therapy. Adv Healthcare Mater 6:1700829.
   Web of Science ®Google Scholar
• He Y, Shao L, Usman I, et al. (2020). A pH-responsive dissociable mesoporous silica-based nanoplatform enabling efficient dual-drug co-delivery and rapid clearance for cancer therapy. Biomater Sci 8:3418–29.
   PubMed Web of Science ®Google Scholar
• Hiremath CG, Heggnnavar GB, Kariduraganavar MY, et al. (2019). Co-delivery of paclitaxel and curcumin to foliate positive cancer cells using pluronic-coated iron oxide nanoparticles. Prog Biomater 8:155–68.
   PubMed Web of Science ®Google Scholar
• Ho JN, Byun SS, Lee S, et al. (2015). Synergistic antitumor effect of triptolide and cisplatin in cisplatin resistant human bladder cancer cells. J Urol 193:1016–22.
   PubMed Web of Science ®Google Scholar
• Hou M, Xue P, Gao YE, et al. (2017). Gemcitabine-camptothecin conjugates: a hybrid prodrug for controlled drug release and synergistic therapeutics. Biomater Sci 5:1889–97.
   PubMed Web of Science ®Google Scholar
• Hu J, Wang J, Wang G, et al. (2016). Pharmacokinetics and antitumor efficacy of DSPE-PEG2000 polymeric liposomes loaded with quercetin and temozolomide: analysis of their effectiveness in enhancing the chemosensitization of drug-resistant glioma cells. Int J Mol Med 37:690–702.
   PubMed Web of Science ®Google Scholar
• Hu L, Pang S, Hu Q, et al. (2015). Enhanced antitumor efficacy of folate targeted nanoparticles co-loaded with docetaxel and curcumin. Biomed Pharmacother 75:26–32.
   PubMed Web of Science ®Google Scholar
• Hu Y, Ran M, Wang B, et al. (2020). Co-delivery of docetaxel and curcumin via nanomicelles for enhancing anti-ovarian cancer treatment. Int J Nanomedicine 15:9703–15.
   PubMed Web of Science ®Google Scholar
• Huang C, Yu Y. (2017). Synergistic cytotoxicity of beta-elemene and cisplatin in gingival squamous cell carcinoma by inhibition of STAT3 signaling pathway. Med Sci Monit 23:1507–13.
   PubMed Web of Science ®Google Scholar
• Huang L, Zhang K, Guo Y, et al. (2017). Honokiol protects against doxorubicin cardiotoxicity via improving mitochondrial function in mouse hearts. Sci Rep 7:11989.
   PubMed Web of Science ®Google Scholar
• Huang L, Zhao S, Fang F, et al. (2021). Advances and perspectives in carrier-free nanodrugs for cancer chemo-monotherapy and combination therapy. Biomaterials 268:120557.
   PubMed Web of Science ®Google Scholar
• Huang PP, Fu J, Liu LH, et al. (2020). Honokiol antagonizes doxorubicininduced cardiomyocyte senescence by inhibiting TXNIP mediated NLRP3 inflammasome activation. Int J Mol Med 45:186–94.
   PubMed Web of Science ®Google Scholar
• Huo M, Wang H, Zhang Y, et al. (2020). Co-delivery of silybin and paclitaxel by dextran-based nanoparticles for effective anti-tumor treatment through chemotherapy sensitization and microenvironment modulation. J Control Release 321:198–210.
   PubMed Web of Science ®Google Scholar
• Jabri T, Imran M, Aziz A, et al. (2019). Design and synthesis of mixed micellar system for enhanced anticancer efficacy of Paclitaxel through its co-delivery with naringin. Drug Dev Ind Pharm 45:703–14.
   PubMed Web of Science ®Google Scholar
• Jacob S, Nair AB, Shah J. (2020). Emerging role of nanosuspensions in drug delivery systems. Biomater Res 24:3.
   PubMedGoogle Scholar
• Jain A, Sharma G, Kushwah V, et al. (2017). Methotrexate and beta-carotene loaded-lipid polymer hybrid nanoparticles: a preclinical study for breast cancer. Nanomedicine (Lond) 12:1851–72.
   PubMed Web of Science ®Google Scholar
• Jia L, Li Z, Shen J, et al. (2015). Multifunctional mesoporous silica nanoparticles mediated co-delivery of paclitaxel and tetrandrine for overcoming multidrug resistance. Int J Pharm 489:318–30.
   PubMed Web of Science ®Google Scholar
• Jiang H, Geng D, Liu H, et al. (2016). Co-delivery of etoposide and curcumin by lipid nanoparticulate drug delivery system for the treatment of gastric tumors. Drug Deliv 23:3665–73.
   PubMed Web of Science ®Google Scholar
• Jiang H, Li ZP, Tian GX, et al. (2019). Liver-targeted liposomes for codelivery of curcumin and combretastatin A4 phosphate: preparation, characterization, and antitumor effects. Int J Nanomedicine 14:1789–804.
   PubMed Web of Science ®Google Scholar
• Jiang L, Li L, He X, et al. (2015). Overcoming drug-resistant lung cancer by paclitaxel loaded dual-functional liposomes with mitochondria targeting and pH-response. Biomaterials 52:126–39.
   PubMed Web of Science ®Google Scholar
• Kabary DM, Helmy MW, Elkhodairy KA, et al. (2018). Hyaluronate/lactoferrin layer-by-layer-coated lipid nanocarriers for targeted co-delivery of rapamycin and berberine to lung carcinoma. Colloids Surf B Biointerfaces 169:183–94.
   PubMed Web of Science ®Google Scholar
• Karaosmanoglu S, Zhou M, Shi B, et al. (2021). Carrier-free nanodrugs for safe and effective cancer treatment. J Control Release 329:805–32.
   PubMed Web of Science ®Google Scholar
• Katiyar SS, Muntimadugu E, Rafeeqi TA, et al. (2016). Co-delivery of rapamycin- and piperine-loaded polymeric nanoparticles for breast cancer treatment. Drug Deliv 23:2608–16.
   PubMed Web of Science ®Google Scholar
• Kazantseva L, Becerra J, Santos-Ruiz L. (2022). Oridonin enhances antitumor effects of doxorubicin in human osteosarcoma cells. Pharmacol Rep 74:248–56.
   PubMed Web of Science ®Google Scholar
• Khaledi S, Jafari S, Hamidi S, et al. (2020). Preparation and characterization of PLGA-PEG-PLGA polymeric nanoparticles for co-delivery of 5-fluorouracil and Chrysin. J Biomater Sci Polym Ed 31:1107–26.
   PubMed Web of Science ®Google Scholar
• Khan I, Joshi G, Nakhate KT, et al. (2019a). Nano-co-delivery of berberine and anticancer drug using PLGA nanoparticles: exploration of better anticancer activity and in vivo kinetics. Pharm Res 36:149.
   PubMed Web of Science ®Google Scholar
• Khan MM, Madni A, Tahir N, et al. (2020). Co-delivery of curcumin and cisplatin to enhance cytotoxicity of cisplatin using lipid-chitosan hybrid nanoparticles. Int J Nanomedicine 15:2207–17.
   PubMed Web of Science ®Google Scholar
• Khan MW, Zhao P, Khan A, et al. (2019b). Synergism of cisplatin-oleanolic acid co-loaded calcium carbonate nanoparticles on hepatocellular carcinoma cells for enhanced apoptosis and reduced hepatotoxicity. Int J Nanomedicine 14:3753–71.
   PubMed Web of Science ®Google Scholar
• Kunjachan S, Rychlik B, Storm G, et al. (2013). Multidrug resistance: physiological principles and nanomedical solutions. Adv Drug Deliv Rev 65:1852–65.
   PubMed Web of Science ®Google Scholar
• Lan JS, Qin YH, Liu L, et al. (2021a). A carrier-free folate receptor-targeted ursolic acid/methotrexate nanodelivery system for synergetic anticancer therapy. Int J Nanomedicine 16:1775–87.
   PubMed Web of Science ®Google Scholar
• Lan M, Lu W, Zou T, et al. (2021b). Role of inflammatory microenvironment: potential implications for improved breast cancer nano-targeted therapy. Cell Mol Life Sci 78:2105–29.
   PubMed Web of Science ®Google Scholar
• Lan Y, Sun Y, Yang T, et al. (2019). Co-delivery of paclitaxel by a capsaicin prodrug micelle facilitating for combination therapy on breast cancer. Mol Pharm 16:3430–40.ma ceut.9b00209
   PubMed Web of Science ®Google Scholar
• Lee S, Lee SK, Jung J. (2021). Potentiating activities of chrysin in the therapeutic efficacy of 5-fluorouracil in gastric cancer cells. Oncol Lett 21:24.
   PubMed Web of Science ®Google Scholar
• Li C, Ge X, Wang L. (2017a). Construction and comparison of different nanocarriers for co-delivery of cisplatin and curcumin: a synergistic combination nanotherapy for cervical cancer. Biomed Pharmacother 86:628–36.
   PubMed Web of Science ®Google Scholar
• Li C, Lin J, Wu P, et al. (2018a). Small molecule nanodrug assembled of dual-anticancer drug conjugate for synergetic cancer metastasis therapy. Bioconjug Chem 29:3495–502.
   PubMed Web of Science ®Google Scholar
• Li D, Cui R, Xu S, et al. (2020a). Synergism of cisplatin-oleanolic acid co-loaded hybrid nanoparticles on gastric carcinoma cells for enhanced apoptosis and reversed multidrug resistance. Drug Deliv 27:191–9.
   PubMed Web of Science ®Google Scholar
• Li H, Li M, Chen C, et al. (2015a). On-demand combinational delivery of curcumin and doxorubicin via a pH-labile micellar nanocarrier. Int J Pharm 495:572–8.
   PubMed Web of Science ®Google Scholar
• Li J, Duan B, Guo Y, et al. (2018b). Baicalein sensitizes hepatocellular carcinoma cells to 5-FU and epirubicin by activating apoptosis and ameliorating P-glycoprotein activity. Biomed Pharmacother 98:806–12.
   PubMed Web of Science ®Google Scholar
• Li J, Zhang J, Wang Y, et al. (2017b). Synergistic inhibition of migration and invasion of breast cancer cells by dual docetaxel/quercetin-loaded nanoparticles via Akt/MMP-9 pathway. Int J Pharm 523:300–9.
   PubMed Web of Science ®Google Scholar
• Li M, Du C, Guo N, et al. (2019a). Composition design and medical application of liposomes. Eur J Med Chem 164:640–53.
   PubMed Web of Science ®Google Scholar
• Li M, Yue X, Wang Y, et al. (2019b). Remodeling the tumor microenvironment to improve drug permeation and antitumor effects by co-delivering quercetin and doxorubicin. J Mater Chem B 7:7619–26.
   PubMed Web of Science ®Google Scholar
• Li N, Guo W, Li Y, et al. (2020b). Construction and anti-tumor activities of disulfide-linked docetaxel-dihydroartemisinin nanoconjugates. Colloids Surf B Biointerfaces 191:111018.
   PubMed Web of Science ®Google Scholar
• Li Q, Fu D, Zhang J, et al. (2021a). Poly(aspartic acid)-based pH-responsive targeting co-delivery nanoparticles. J Biomater Appl 36:579–91.
   PubMed Web of Science ®Google Scholar
• Li Q, Fu D, Zhang J, et al. (2021b). Dual stimuli-responsive polypeptide-calcium phosphate hybrid nanoparticles for co-delivery of multiple drugs in cancer therapy. Colloids Surf B Biointerfaces 200:111586.
   PubMed Web of Science ®Google Scholar
• Li S, Wang L, Li N, et al. (2017c). Combination lung cancer chemotherapy: design of a pH-sensitive transferrin-PEG-Hz-lipid conjugate for the co-delivery of docetaxel and baicalin. Biomed Pharmacother 95:548–55.
   PubMed Web of Science ®Google Scholar
• Li W, Hu X, Wang S, et al. (2020c). Characterization and anti-tumor bioactivity of astragalus polysaccharides by immunomodulation. Int J Biol Macromol 145:985–97.
   PubMed Web of Science ®Google Scholar
• Li WM, Chiang CS, Huang WC, et al. (2015b). Amifostine-conjugated pH-sensitive calcium phosphate-covered magnetic-amphiphilic gelatin nanoparticles for controlled intracellular dual drug release for dual-targeting in HER-2-overexpressing breast cancer. J Control Release 220:107–18.
   PubMed Web of Science ®Google Scholar
• Li X, Yang S, Wang L, et al. (2019c). Resveratrol inhibits paclitaxel-induced neuropathic pain by the activation of PI3K/Akt and SIRT1/PGC1alpha pathway. JPR 12:879–90. S185873
   Web of Science ®Google Scholar
• Li X, Yu N, Li J, et al. (2020d). Novel "carrier-free" nanofiber codelivery systems with the synergistic antitumor effect of paclitaxel and tetrandrine through the enhancement of mitochondrial apoptosis. ACS Appl Mater Interfaces 12:10096–106.
   PubMed Web of Science ®Google Scholar
• Li Y, Li D, Wang P, et al. (2020e). Tetrandrine partially reverses multidrug resistance of human laryngeal cancer cells. J Int Med Res 48:300060520944706.
   PubMed Web of Science ®Google Scholar
• Li Y, Li X, Lu Y, et al. (2020f). Co-delivery of Poria cocos extract and doxorubicin as an ‘all-in-one’ nanocarrier to combat breast cancer multidrug resistance during chemotherapy. Nanomedicine 23:102095.
   PubMed Web of Science ®Google Scholar
• Li Y, Lin J, Ma J, et al. (2017d). Methotrexate-camptothecin prodrug nanoassemblies as a versatile nanoplatform for biomodal imaging-guided self-active targeted and synergistic chemotherapy. ACS Appl Mater Interfaces 9:34650–65.
   PubMed Web of Science ®Google Scholar
• Li Z, Zhang Y, Zhu C, et al. (2020g). Folic acid modified lipid-bilayer coated mesoporous silica nanoparticles co-loading paclitaxel and tanshinone IIA for the treatment of acute promyelocytic leukemia. Int J Pharm 586:119576.
   PubMed Web of Science ®Google Scholar
• Liao D, Zhang W, Gupta P, et al. (2019). Tetrandrine interaction with ABCB1 reverses multidrug resistance in cancer cells through competition with anti-cancer drugs followed by downregulation of ABCB1 expression. Molecules 24:4383.
   PubMed Web of Science ®Google Scholar
• Lin D, Lin W, Gao G, et al. (2020). Purification and characterization of the major protein isolated from Semen Armeniacae Amarum and the properties of its thermally induced nanoparticles. Int J Biol Macromol 159:850–8.
   PubMed Web of Science ®Google Scholar
• Lin J, Cai Q, Tang Y, et al. (2018). PEGylated lipid bilayer coated mesoporous silica nanoparticles for co-delivery of paclitaxel and curcumin: design, characterization and its cytotoxic effect. Int J Pharm 536:272–82.
   PubMed Web of Science ®Google Scholar
• Lin JT, Ye QB, Yang QJ, et al. (2019). Hierarchical bioresponsive nanocarriers for codelivery of curcumin and doxorubicin. Colloids Surf B Biointerfaces 180:93–101.
   PubMed Web of Science ®Google Scholar
• Liu H, Yuan M, Liu Y, et al. (2021a). Self-monitoring and self-delivery of self-assembled fluorescent nanoparticles in cancer therapy. Int J Nanomedicine 16:2487–99.
   PubMed Web of Science ®Google Scholar
• Liu J, Cheng H, Han L, et al. (2018). Synergistic combination therapy of lung cancer using paclitaxel- and triptolide-coloaded lipid-polymer hybrid nanoparticles. Drug Des Devel Ther 12:3199–209.
   PubMed Web of Science ®Google Scholar
• Liu K, Chen W, Yang T, et al. (2017). Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery. Int J Nanomedicine 12:8239–55.
   PubMed Web of Science ®Google Scholar
• Liu L, Qi XJ, Zhong ZK, et al. (2016a). Nanomedicine-based combination of gambogic acid and retinoic acid chlorochalcone for enhanced anticancer efficacy in osteosarcoma. Biomed Pharmacother 83:79–84.
   PubMed Web of Science ®Google Scholar
• Liu M, Fu M, Yang X, et al. (2020a). Paclitaxel and quercetin co-loaded functional mesoporous silica nanoparticles overcoming multidrug resistance in breast cancer. Colloids Surf B Biointerfaces 196:111284.
   PubMed Web of Science ®Google Scholar
• Liu Q, Li J, Pu G, et al. (2016b). Co-delivery of baicalein and doxorubicin by hyaluronic acid decorated nanostructured lipid carriers for breast cancer therapy. Drug Deliv 23:1364–8.
   PubMed Web of Science ®Google Scholar
• Liu Y, Yang S, Wang K, et al. (2020b). Cellular senescence and cancer: focusing on traditional Chinese medicine and natural products. Cell Prolif 53:e12894.
   PubMed Web of Science ®Google Scholar
• Liu Z, Chu W, Sun Q, et al. (2021b). Micelle-contained and PEGylated hybrid liposomes of combined gemcitabine and cisplatin delivery for enhancing antitumor activity. Int J Pharm 602:120619.
   PubMed Web of Science ®Google Scholar
• Lockhart JN, Stevens DM, Beezer DB, et al. (2015). Dual drug delivery of tamoxifen and quercetin: regulated metabolism for anticancer treatment with nanosponges. J Control Release 220:751–7.
   PubMed Web of Science ®Google Scholar
• Lőrincz A, Mihály J, Wacha A, et al. (2021). Combination of multifunctional ursolic acid with kinase inhibitors for anti-cancer drug carrier vesicles. Mater Sci Eng C Mater Biol Appl 131:112481.
   PubMed Web of Science ®Google Scholar
• Lu L, Zhang M, Wang X, et al. (2020a). Baicalein enhances the antitumor efficacy of docetaxel on nonsmall cell lung cancer in a beta-catenin-dependent manner. Phytother Res 34:104–17.
   PubMed Web of Science ®Google Scholar
• Lu X, Yang F, Chen D, et al. (2020b). Quercetin reverses docetaxel resistance in prostate cancer via androgen receptor and PI3K/Akt signaling pathways. Int J Biol Sci 16:1121–34.
   PubMed Web of Science ®Google Scholar
• Lu Y, Wang J, Liu L, et al. (2017a). Curcumin increases the sensitivity of Paclitaxel-resistant NSCLC cells to paclitaxel through microRNA-30c-mediated MTA1 reduction. Tumour Biol 39:1010428317698353.
   Google Scholar
• Lu Z, Su J, Li Z, et al. (2017b). Hyaluronic acid-coated, prodrug-based nanostructured lipid carriers for enhanced pancreatic cancer therapy. Drug Dev Ind Pharm 43:160–70.
   PubMed Web of Science ®Google Scholar
• Lv L, Liu C, Chen C, et al. (2016a). Quercetin and doxorubicin co-encapsulated biotin receptor-targeting nanoparticles for minimizing drug resistance in breast cancer. Oncotarget 7:32184–99.
   PubMedGoogle Scholar
• Lv L, Qiu K, Yu X, et al. (2016b). Amphiphilic copolymeric micelles for doxorubicin and curcumin co-delivery to reverse multidrug resistance in breast cancer. J Biomed Nanotechnol 12:973–85.
   PubMed Web of Science ®Google Scholar
• Lv X, Zhu Y, Deng Y, et al. (2020). Glycyrrhizin improved autophagy flux via HMGB1-dependent Akt/mTOR signaling pathway to prevent doxorubicin-induced cardiotoxicity. Toxicology 441:152508.
   PubMed Web of Science ®Google Scholar
• Ma X, Yang S, Zhang T, et al. (2022). Bioresponsive immune-booster-based prodrug nanogel for cancer immunotherapy. Acta Pharm Sin B 12:451–66.
   PubMed Web of Science ®Google Scholar
• Mahira S, Kommineni N, Husain GM, et al. (2019). Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: a new insight into nanomedicine based combinational chemotherapy for prostate cancer. Biomed Pharmacother 110:803–17.
   PubMed Web of Science ®Google Scholar
• Mahmoudi R, Hassandokht F, Ardakani MT, et al. (2021). Intercalation of curcumin into liposomal chemotherapeutic agent augments apoptosis in breast cancer cells. J Biomater Appl 35:1005–18.
   PubMed Web of Science ®Google Scholar
• Majidinia M, Mirza-Aghazadeh-Attari M, Rahimi M, et al. (2020). Overcoming multidrug resistance in cancer: recent progress in nanotechnology and new horizons. IUBMB Life 72:855–71.
   PubMed Web of Science ®Google Scholar
• Maleki H, Hosseini Najafabadi MR, Webster TJ, et al. (2021). Effect of paclitaxel/etoposide co-loaded polymeric nanoparticles on tumor size and survival rate in a rat model of glioblastoma. Int J Pharm 604:120722.
   PubMed Web of Science ®Google Scholar
• Martinez-Edo G, Fornaguera C, Borros S, et al. (2020). Glycyrrhetinic acid-functionalized mesoporous silica nanoparticles for the co-delivery of DOX/CPT-PEG for targeting HepG2 cells. Pharmaceutics 12:1048.
   PubMed Web of Science ®Google Scholar
• Meng J, Guo F, Xu H, et al. (2016a). Combination therapy using co-encapsulated resveratrol and paclitaxel in liposomes for drug resistance reversal in breast cancer cells in vivo. Sci Rep 6:22390.
   PubMed Web of Science ®Google Scholar
• Meng L, Xia X, Yang Y, et al. (2016b). Co-encapsulation of paclitaxel and baicalein in nanoemulsions to overcome multidrug resistance via oxidative stress augmentation and P-glycoprotein inhibition. Int J Pharm 513:8–16.
   PubMed Web of Science ®Google Scholar
• Mi FL, Wang LF, Chu PY, et al. (2018). Active tumor-targeted co-delivery of epigallocatechin gallate and doxorubicin in nanoparticles for combination gastric cancer therapy. ACS Biomater Sci Eng 4:2847–59.
   PubMed Web of Science ®Google Scholar
• Mohammad IS, He W, Yin L. (2020). Insight on multidrug resistance and nanomedicine approaches to overcome MDR. Crit Rev Ther Drug Carrier Syst 37:473–509.
   PubMed Web of Science ®Google Scholar
• Mohanty AK, Mohanta GP. (2015). Micelle-assisted combination therapies for effective glioblastoma treatment: an in-vitro assessment. Anticancer Drugs 26:312–22.
   PubMed Web of Science ®Google Scholar
• Muthusamy G, Balupillai A, Ramasamy K, et al. (2016). Ferulic acid reverses ABCB1-mediated paclitaxel resistance in MDR cell lines. Eur J Pharmacol 786:194–203.
   PubMed Web of Science ®Google Scholar
• Nguyen NT, Nguyen NNT, Tran NTN, et al. (2018). Synergic activity against MCF-7 breast cancer cell growth of nanocurcumin-encapsulated and cisplatin-complexed nanogels. Molecules 23:3347.
   PubMed Web of Science ®Google Scholar
• Oz M, Nurullahoglu Atalik KE, Yerlikaya FH, et al. (2015). Curcumin alleviates cisplatin-induced learning and memory impairments. Neurobiol Learn Mem 123:43–9.
   PubMed Web of Science ®Google Scholar
• Ozkaya D, Naziroglu M. (2020). Curcumin diminishes cisplatin-induced apoptosis and mitochondrial oxidative stress through inhibition of TRPM2 channel signaling pathway in mouse optic nerve. J Recept Signal Transduct Res 40:97–108.
   PubMed Web of Science ®Google Scholar
• Ozturk Y, Gunaydin C, Yalcin F, et al. (2019). Resveratrol enhances apoptotic and oxidant effects of paclitaxel through TRPM2 channel activation in DBTRG glioblastoma cells. Oxid Med Cell Longev 2019:4619865.
   PubMed Web of Science ®Google Scholar
• Pang L, Zhang L, Zhou H, et al. (2022). Reactive oxygen species-responsive nanococktail with self-amplificated drug release for efficient co-delivery of paclitaxel/cucurbitacin B and synergistic treatment of gastric cancer. Front Chem 10:844426.
   PubMed Web of Science ®Google Scholar
• Pangeni R, Panthi VK, Yoon IS, et al. (2018). Preparation, characterization, and in vivo evaluation of an oral multiple nanoemulsive system for co-delivery of pemetrexed and quercetin. Pharmaceutics 10:158.
   PubMed Web of Science ®Google Scholar
• Peng J, Fumoto S, Miyamoto H, et al. (2017). One-step formation of lipid-polyacrylic acid-calcium carbonate nanoparticles for co-delivery of doxorubicin and curcumin. J Drug Target 25:704–14.
   PubMed Web of Science ®Google Scholar
• Phung CD, Le TG, Nguyen VH, et al. (2020). PEGylated-paclitaxel and dihydroartemisinin nanoparticles for simultaneously delivering paclitaxel and dihydroartemisinin to colorectal cancer. Pharm Res 37:129.
   PubMed Web of Science ®Google Scholar
• Pillai VB, Kanwal A, Fang YH, et al. (2017). Honokiol, an activator of Sirtuin-3 (SIRT3) preserves mitochondria and protects the heart from doxorubicin-induced cardiomyopathy in mice. Oncotarget 8:34082–98.
   PubMedGoogle Scholar
• Potocnjak I, Simic L, Vukelic I, et al. (2019). Oleanolic acid attenuates cisplatin-induced nephrotoxicity in mice and chemosensitizes human cervical cancer cells to cisplatin cytotoxicity. Food Chem Toxicol 132:110676.
   PubMed Web of Science ®Google Scholar
• Qi M, Zou S, Guo C, et al. (2018). Enhanced in vitro and in vivo anticancer properties by using a nanocarrier for co-delivery of antitumor polypeptide and curcumin. J Biomed Nanotechnol 14:139–49.
   PubMed Web of Science ®Google Scholar
• Qi SS, Sun JH, Yu HH, et al. (2017). Co-delivery nanoparticles of anti-cancer drugs for improving chemotherapy efficacy. Drug Deliv 24:1909–26.
   PubMed Web of Science ®Google Scholar
• Quagliariello V, Iaffaioli RV, Armenia E, et al. (2017). Hyaluronic acid nanohydrogel loaded with quercetin alone or in combination to a macrolide derivative of rapamycin RAD001 (everolimus) as a new treatment for hormone-responsive human breast cancer. J Cell Physiol 232:2063–74.
   PubMed Web of Science ®Google Scholar
• Rawal S, Bora V, Patel B, et al. (2020a). Surface-engineered nanostructured lipid carrier systems for synergistic combination oncotherapy of non-small cell lung cancer. Drug Deliv Transl Res 11:2030–51.
   PubMed Web of Science ®Google Scholar
• Rawal S, Patel B, Patel MM. (2020b). Fabrication, optimisation and in vitro evaluation of docetaxel and curcumin co-loaded nanostructured lipid carriers for improved antitumor activity against non-small cell lung carcinoma. J Microencapsul 37:543–56.
   PubMed Web of Science ®Google Scholar
• Ren Y, Li X, Han B, et al. (2019). Improved anti-colorectal carcinomatosis effect of tannic acid co-loaded with oxaliplatin in nanoparticles encapsulated in thermosensitive hydrogel. Eur J Pharm Sci 128:279–89.
   PubMed Web of Science ®Google Scholar
• Rudnik LAC, Farago PV, Manfron Budel J, et al. (2020). Co-loaded curcumin and methotrexate nanocapsules enhance cytotoxicity against non-small-cell lung cancer cells. Molecules 25:1913.
   PubMed Web of Science ®Google Scholar
• Ruttala HB, Ko YT. (2015). Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy. Colloids Surf B Biointerfaces 128:419–26.
   PubMed Web of Science ®Google Scholar
• Sabra SA, Elzoghby AO, Sheweita SA, et al. (2018). Self-assembled amphiphilic zein-lactoferrin micelles for tumor targeted co-delivery of rapamycin and wogonin to breast cancer. Eur J Pharm Biopharm 128:156–69.
   PubMed Web of Science ®Google Scholar
• Sabzi A, Rahmani A, Edalati M, et al. (2020). Targeted co-delivery of curcumin and doxorubicin by citric acid functionalized Poly (epsilon-caprolactone) based micelle in MDA-MB-231 cell. Colloids Surf B Biointerfaces 194:111225.
   PubMed Web of Science ®Google Scholar
• Sahu BP, Hazarika H, Bharadwaj R, et al. (2016). Curcumin-docetaxel co-loaded nanosuspension for enhanced anti-breast cancer activity. Expert Opin Drug Deliv 13:1065–74.
   PubMed Web of Science ®Google Scholar
• Saneja A, Kumar R, Mintoo MJ, et al. (2019). Gemcitabine and betulinic acid co-encapsulated PLGA-PEG polymer nanoparticles for improved efficacy of cancer chemotherapy. Mater Sci Eng C Mater Biol Appl 98:764–71.
   PubMed Web of Science ®Google Scholar
• Sang DP, Li RJ, Lan Q. (2014). Quercetin sensitizes human glioblastoma cells to temozolomide in vitro via inhibition of Hsp27. Acta Pharmacol Sin 35:832–8.
   PubMed Web of Science ®Google Scholar
• Sarisozen C, Dhokai S, Tsikudo EG, et al. (2016). Nanomedicine based curcumin and doxorubicin combination treatment of glioblastoma with scFv-targeted micelles: In vitro evaluation on 2D and 3D tumor models. Eur J Pharm Biopharm 108:54–67.
   PubMed Web of Science ®Google Scholar
• Sesarman A, Tefas L, Sylvester B, et al. (2019). Co-delivery of curcumin and doxorubicin in PEGylated liposomes favored the antineoplastic C26 murine colon carcinoma microenvironment. Drug Deliv Transl Res 9:260–72.
   PubMed Web of Science ®Google Scholar
• Shao Y, Luo W, Guo Q, et al. (2019). In vitro and in vivo effect of hyaluronic acid modified, doxorubicin and gallic acid co-delivered lipid-polymeric hybrid nano-system for leukemia therapy. Drug Des Devel Ther 13:2043–55.
   PubMed Web of Science ®Google Scholar
• Shen Q, Qiu L. (2017). Reversal of P-glycoprotein-mediated multidrug resistance by doxorubicin and quinine co-loaded liposomes in tumor cells. J Liposome Res 27:293–301.
   PubMed Web of Science ®Google Scholar
• Shen S, Xu X, Lin S, et al. (2021). A nanotherapeutic strategy to overcome chemotherapeutic resistance of cancer stem-like cells. Nat Nanotechnol 16:104–13.
   PubMed Web of Science ®Google Scholar
• Siegel RL, Miller KD, Fuchs HE, et al. (2021). Cancer Statistics, 2021. CA Cancer J Clin 71:7–33.
   PubMed Web of Science ®Google Scholar
• Soetikno V, Sari SDP, Ul Maknun L, et al. (2019). Pre-treatment with curcumin ameliorates cisplatin-induced kidney damage by suppressing kidney inflammation and apoptosis in rats. Drug Res (Stuttg) 69:75–82.
   PubMed Web of Science ®Google Scholar
• Sohail M, Guo W, Li Z, et al. (2021). Nanocarrier-based drug delivery system for cancer therapeutics: a review of the last decade. Curr Med Chem 28:3753–72.
   PubMed Web of Science ®Google Scholar
• Song Z, Shi Y, Han Q, et al. (2018). Endothelial growth factor receptor-targeted and reactive oxygen species-responsive lung cancer therapy by docetaxel and resveratrol encapsulated lipid-polymer hybrid nanoparticles. Biomed Pharmacother 105:18–26.
   PubMed Web of Science ®Google Scholar
• Sun G, Sun K, Sun J. (2021a). Combination prostate cancer therapy: prostate-specific membranes antigen targeted, pH-sensitive nanoparticles loaded with doxorubicin and tanshinone. Drug Deliv 28:1132–40.
   PubMed Web of Science ®Google Scholar
• Sun L, Cao J, Chen K, et al. (2019). Betulinic acid inhibits stemness and EMT of pancreatic cancer cells via activation of AMPK signaling. Int J Oncol 54:98–110.
   PubMed Web of Science ®Google Scholar
• Sun Y, Ma X, Hu H. (2021b). Marine polysaccharides as a versatile biomass for the construction of nano drug delivery systems. Mar Drugs 19:345.
   PubMed Web of Science ®Google Scholar
• Tai W, Mo R, Lu Y, et al. (2014). Folding graft copolymer with pendant drug segments for co-delivery of anticancer drugs. Biomaterials 35:7194–203.
   PubMed Web of Science ®Google Scholar
• Tang Y, Liang J, Wu A, et al. (2017). Co-delivery of trichosanthin and albendazole by nano-self-assembly for overcoming tumor multidrug-resistance and metastasis. ACS Appl Mater Interfaces 9:26648–64.
   PubMed Web of Science ®Google Scholar
• Tapeinos C, Battaglini M, Ciofani G. (2017). Advances in the design of solid lipid nanoparticles and nanostructured lipid carriers for targeting brain diseases. J Control Release 264:306–32.
   PubMed Web of Science ®Google Scholar
• Tefas LR, Sylvester B, Tomuta I, et al. (2017). Development of antiproliferative long-circulating liposomes co-encapsulating doxorubicin and curcumin, through the use of a quality-by-design approach. Drug Des Devel Ther 11:1605–21.
   PubMed Web of Science ®Google Scholar
• Thandavarayan RA, Giridharan VV, Arumugam S, et al. (2015). Schisandrin B prevents doxorubicin induced cardiac dysfunction by modulation of DNA damage, oxidative stress and inflammation through inhibition of MAPK/p53 signaling. PLoS One 10:e0119214.
   PubMed Web of Science ®Google Scholar
• Vakilinezhad MA, Amini A, Dara T, et al. (2019). Methotrexate and curcumin co-encapsulated PLGA nanoparticles as a potential breast cancer therapeutic system: In vitro and in vivo evaluation. Colloids Surf B Biointerfaces 184:110515.
   PubMed Web of Science ®Google Scholar
• Varshosaz J, Jandaghian S, Mirian M, et al. (2021). Co-delivery of rituximab targeted curcumin and imatinib nanostructured lipid carriers in non-Hodgkin lymphoma cells. J Liposome Res 31:64–78.
   PubMed Web of Science ®Google Scholar
• Vinod BS, Nair HH, Vijayakurup V, et al. (2015). Resveratrol chemosensitizes HER-2-overexpressing breast cancer cells to docetaxel chemoresistance by inhibiting docetaxel-mediated activation of HER-2-Akt axis. Cell Death Discov 1:15061.
   PubMed Web of Science ®Google Scholar
• Wan X, Beaudoin JJ, Vinod N, et al. (2019). Co-delivery of paclitaxel and cisplatin in poly(2-oxazoline) polymeric micelles: implications for drug loading, release, pharmacokinetics and outcome of ovarian and breast cancer treatments. Biomaterials 192:1–14.
   PubMed Web of Science ®Google Scholar
• Wang B, Gou M, Zheng X, et al. (2010). Co-delivery honokiol and doxorubicin in MPEG-PLA nanoparticles. J Nanosci Nanotechnol 10:4166–72.
   PubMed Web of Science ®Google Scholar
• Wang C, Su L, Wu C, et al. (2016). RGD peptide targeted lipid-coated nanoparticles for combinatorial delivery of sorafenib and quercetin against hepatocellular carcinoma. Drug Dev Ind Pharm 42:1938–44.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhu J, Ma J, et al. (2019a). Functionalized Bletilla striata polysaccharide micelles for targeted intracellular delivery of doxorubicin: in vitro and in vivo evaluation. Int J Pharm 567:118436.
   PubMed Web of Science ®Google Scholar
• Wang J, Ma W, Tu P. (2015a). Synergistically improved anti-tumor efficacy by co-delivery doxorubicin and curcumin polymeric micelles. Macromol Biosci 15:1252–61.
   PubMed Web of Science ®Google Scholar
• Wang MZ, He X, Yu Z, et al. (2020). A nano drug delivery system based on Angelica sinensis polysaccharide for combination of chemotherapy and immunotherapy. Molecules 25:3096.
   PubMed Web of Science ®Google Scholar
• Wang QS, Gao LN, Zhu XN, et al. (2019b). Co-delivery of glycyrrhizin and doxorubicin by alginate nanogel particles attenuates the activation of macrophage and enhances the therapeutic efficacy for hepatocellular carcinoma. Theranostics 9:6239–55.
   PubMed Web of Science ®Google Scholar
• Wang R, Huang J, Chen J, et al. (2019c). Enhanced anti-colon cancer efficacy of 5-fluorouracil by epigallocatechin-3-gallate co-loaded in wheat germ agglutinin-conjugated nanoparticles. Nanomedicine 21:102068.
   PubMed Web of Science ®Google Scholar
• Wang R, Yang M, Li G, et al. (2019d). Paclitaxel-betulinic acid hybrid nanosuspensions for enhanced anti-breast cancer activity. Colloids Surf B Biointerfaces 174:270–9.
   PubMed Web of Science ®Google Scholar
• Wang S, Wang A, Shao M, et al. (2017). Schisandrin B reverses doxorubicin resistance through inhibiting P-glycoprotein and promoting proteasome-mediated degradation of survivin. Sci Rep 7:8419.
   PubMed Web of Science ®Google Scholar
• Wang W, Xi M, Duan X, et al. (2015b). Delivery of baicalein and paclitaxel using self-assembled nanoparticles: synergistic antitumor effect in vitro and in vivo. Int J Nanomedicine 10:3737–50.
   PubMed Web of Science ®Google Scholar
• Wang X, Liu Y, Xu W, et al. (2021). Irinotecan and berberine co-delivery liposomes showed improved efficacy and reduced intestinal toxicity compared with onivyde for pancreatic cancer. Drug Deliv Transl Res 11:2186–97.
   Web of Science ®Google Scholar
• Wu L, Cao K, Ni Z, et al. (2019a). Rhein reverses doxorubicin resistance in SMMC-7721 liver cancer cells by inhibiting energy metabolism and inducing mitochondrial permeability transition pore opening. Biofactors 45:85–96.
   PubMed Web of Science ®Google Scholar
• Wu L, Liu X, Cao KX, et al. (2020a). Synergistic antitumor effects of rhein and doxorubicin in hepatocellular carcinoma cells. J Cell Biochem 121:4009–21.
   PubMed Web of Science ®Google Scholar
• Wu YZ, Zhang L, Wu ZX, et al. (2019b). Berberine ameliorates doxorubicin-induced cardiotoxicity via a SIRT1/p66Shc-mediated pathway. Oxid Med Cell Longev 2019:2150394.
   PubMed Web of Science ®Google Scholar
• Wu Z, Li S, Cai Y, et al. (2020b). Synergistic action of doxorubicin and 7-ethyl-10-hydroxycamptothecin polyphosphorylcholine polymer prodrug. Colloids Surf B Biointerfaces 189:110741.
   PubMed Web of Science ®Google Scholar
• Xiao H, Xiong L, Song X, et al. (2017). Angelica sinensis polysaccharides ameliorate stress-induced premature senescence of hematopoietic cell via protecting bone marrow stromal cells from oxidative injuries caused by 5-fluorouracil. Int J Mol Sci 18:2265.
   PubMed Web of Science ®Google Scholar
• Xiao Y, Zhang T, Ma X, et al. (2021). Microenvironment-responsive prodrug-induced pyroptosis boosts cancer immunotherapy. Adv Sci (Weinh) 8:e2101840.
   PubMedGoogle Scholar
• Xiong K, Zhang Y, Wen Q, et al. (2020). Co-delivery of paclitaxel and curcumin by biodegradable polymeric nanoparticles for breast cancer chemotherapy. Int J Pharm 589:119875.
   PubMed Web of Science ®Google Scholar
• Xu H, Lu X, Li J, et al. (2017a). Superior antitumor effect of extremely high drug loading self-assembled paclitaxel nanofibers. Int J Pharm 526:217–24.
   PubMed Web of Science ®Google Scholar
• Xu J, Geng MY, Hang M. (2019a). Mechanistic advancement in chemotherapeutic agents modulated antitumor immune response. Acta Pharmaceutica Sinica 54:1741–8.
   Google Scholar
• Xu J, Liu D, Niu H, et al. (2017b). Resveratrol reverses Doxorubicin resistance by inhibiting epithelial-mesenchymal transition (EMT) through modulating PTEN/Akt signaling pathway in gastric cancer. J Exp Clin Cancer Res 36:19.
   PubMed Web of Science ®Google Scholar
• Xu M, Li G, Zhang H, et al. (2020). Sequential delivery of dual drugs with nanostructured lipid carriers for improving synergistic tumor treatment effect. Drug Deliv 27:983–95.
   PubMed Web of Science ®Google Scholar
• Xu Y, Huang Y, Lu W, et al. (2019b). 4-Carboxyphenylboronic acid-decorated, redox-sensitive rod-shaped nano-micelles fabricated through co-assembling strategy for active targeting and synergistic co-delivery of camptothecin and gemcitabine. Eur J Pharm Biopharm 144:193–206.
   PubMed Web of Science ®Google Scholar
• Xu Y, Huang Y, Zhang X, et al. (2018). Carrier-free Janus nano-prodrug based on camptothecin and gemcitabine: reduction-triggered drug release and synergistic in vitro antiproliferative effect in multiple cancer cells. Int J Pharm 550:45–56.
   PubMed Web of Science ®Google Scholar
• Xu Y, Liu Y, Liu Q, et al. (2021). Co-delivery of bufalin and nintedanib via albumin sub-microspheres for synergistic cancer therapy. J Control Release 338:705–18.
   Web of Science ®Google Scholar
• Xu Y, Wang C, Ding Y, et al. (2016). Nanoparticles with optimal ratiometric co-delivery of docetaxel with gambogic acid for treatment of multidrug-resistant breast cancer. J Biomed Nanotechnol 12:1774–81.
   PubMed Web of Science ®Google Scholar
• Xue P, Liu D, Wang J, et al. (2016). Redox-sensitive citronellol-cabazitaxel conjugate: maintained in vitro cytotoxicity and self-assembled as multifunctional nanomedicine. Bioconjug Chem 27:1360–72.
   PubMed Web of Science ®Google Scholar
• Yan J, Wang Y, Jia Y, et al. (2017). Co-delivery of docetaxel and curcumin prodrug via dual-targeted nanoparticles with synergistic antitumor activity against prostate cancer. Biomed Pharmacother 88:374–83.
   PubMed Web of Science ®Google Scholar
• Yang M, Li J, Gu P, et al. (2021). The application of nanoparticles in cancer immunotherapy: targeting tumor microenvironment. Bioact Mater 6:1973–87.
   PubMed Web of Science ®Google Scholar
• Yang Z, Sun N, Cheng R, et al. (2017a). Hybrid nanoparticles coated with hyaluronic acid lipoid for targeted co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells. J Mater Chem B 5:6762–75.
   PubMed Web of Science ®Google Scholar
• Yang Z, Sun N, Cheng R, et al. (2017b). pH multistage responsive micellar system with charge-switch and PEG layer detachment for co-delivery of paclitaxel and curcumin to synergistically eliminate breast cancer stem cells. Biomaterials 147:53–67.
   PubMed Web of Science ®Google Scholar
• Yao Q, Gutierrez DC, Hoang NH, et al. (2017). Efficient codelivery of paclitaxel and curcumin by novel bottlebrush copolymer-based micelles. Mol Pharm 14:2378–89.
   PubMed Web of Science ®Google Scholar
• Yin J, Li Q, Sun LD, et al. (2019). Research advancement in natural anti-cancer product. Zhongguo Zhong Yao Za Zhi 44:19–27.
   PubMedGoogle Scholar
• Yokoyama M. (2014). Polymeric micelles as drug carriers: their lights and shadows. J Drug Target 22:576–83.
   PubMed Web of Science ®Google Scholar
• Yu M, Qi B, Xiaoxiang W, et al. (2017). Baicalein increases cisplatin sensitivity of A549 lung adenocarcinoma cells via PI3K/Akt/NF-kappaB pathway. Biomed Pharmacother 90:677–85.
   PubMed Web of Science ®Google Scholar
• Yu X, Sun L, Tan L, et al. (2020). Preparation and characterization of PLGA-PEG-PLGA nanoparticles containing salidroside and tamoxifen for breast cancer therapy. AAPS PharmSciTech 21:85.
   PubMed Web of Science ®Google Scholar
• Yuan CH, Horng CT, Lee CF, et al. (2017). Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling. Environ Toxicol 32:845–55.
   PubMed Web of Science ®Google Scholar
• Yukuyama MN, Kato ETM, Lobenberg R, et al. (2017). Challenges and future prospects of nanoemulsion as a drug delivery system. Curr Pharm Des 23:495–508.
   PubMed Web of Science ®Google Scholar
• Zan Y, Dai Z, Liang L, et al. (2019). Co-delivery of plantamajoside and sorafenib by a multi-functional nanoparticle to combat the drug resistance of hepatocellular carcinoma through reprograming the tumor hypoxic microenvironment. Drug Deliv 26:1080–91.
   PubMed Web of Science ®Google Scholar
• Zang X, Cheng M, Zhang X, et al. (2021). Quercetin nanoformulations: a promising strategy for tumor therapy. Food Funct 12:6664–81.
   PubMed Web of Science ®Google Scholar
• Zeng X, Zhang Y, Xu X, et al. (2022). Construction of pH-sensitive targeted micelle system co-delivery with curcumin and dasatinib and evaluation of anti-liver cancer. Drug Deliv 29:792–806.
   PubMed Web of Science ®Google Scholar
• Zeng YY, Zeng YJ, Zhang NN, et al. (2019). The preparation, determination of a flexible complex liposome co-loaded with cabazitaxel and β-elemene, and animal pharmacodynamics on paclitaxel-resistant lung adenocarcinoma. Molecules 24:1697.
   PubMed Web of Science ®Google Scholar
• Zhai B, Zhang N, Han X, et al. (2019). Molecular targets of β-elemene, a herbal extract used in traditional Chinese medicine, and its potential role in cancer therapy: a review. Biomed Pharmacother 114:108812.
   PubMed Web of Science ®Google Scholar
• Zhan XK, Li JL, Zhang S, et al. (2018). Betulinic acid exerts potent antitumor effects on paclitaxel-resistant human lung carcinoma cells (H460) via G2/M phase cell cycle arrest and induction of mitochondrial apoptosis. Oncol Lett 16:3628–34.
   PubMed Web of Science ®Google Scholar
• Zhang D, Xu Q, Wang N, et al. (2018a). A complex micellar system co-delivering curcumin with doxorubicin against cardiotoxicity and tumor growth. Int J Nanomedicine 13:4549–61.
   PubMed Web of Science ®Google Scholar
• Zhang F, Jia Y, Zheng X, et al. (2019a). Janus nanocarrier-based co-delivery of doxorubicin and berberine weakens chemotherapy-exacerbated hepatocellular carcinoma recurrence. Acta Biomater 100:352–64.
   PubMed Web of Science ®Google Scholar
• Zhang H, Tian Y, Zhu Z, et al. (2016a). Efficient antitumor effect of co-drug-loaded nanoparticles with gelatin hydrogel by local implantation. Sci Rep 6:26546.
   PubMed Web of Science ®Google Scholar
• Zhang J, Hu K, Di L, et al. (2021a). Traditional herbal medicine and nanomedicine: converging disciplines to improve therapeutic efficacy and human health. Adv Drug Deliv Rev 178:113964.
   PubMed Web of Science ®Google Scholar
• Zhang J, Li J, Shi Z, et al. (2017a). pH-sensitive polymeric nanoparticles for co-delivery of doxorubicin and curcumin to treat cancer via enhanced pro-apoptotic and anti-angiogenic activities. Acta Biomater 58:349–64.
   PubMed Web of Science ®Google Scholar
• Zhang J, Wang L, Fai Chan H, et al. (2017b). Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells. Sci Rep 7:46057.
   PubMed Web of Science ®Google Scholar
• Zhang L, Zhu H, Gu Y, et al. (2019b). Dual drug-loaded PLA nanoparticles bypassing drug resistance for improved leukemia therapy. J Nanopart Res 21:83.
   Web of Science ®Google Scholar
• Zhang R, Lu M, Zhang Z, et al. (2016b). Resveratrol reverses P-glycoprotein-mediated multidrug resistance of U2OS/ADR cells by suppressing the activation of the NF-kappaB and p38 MAPK signaling pathways. Oncol Lett 12:4147–54.
   PubMed Web of Science ®Google Scholar
• Zhang R, Zhang Y, Zhang Y, et al. (2020a). Ratiometric delivery of doxorubicin and berberine by liposome enables superior therapeutic index than DoxilⓇ. Asian J Pharm Sci 15:385–96.
   PubMed Web of Science ®Google Scholar
• Zhang S, Guo W. (2021). β-elemene enhances the sensitivity of osteosarcoma cells to doxorubicin via downregulation of peroxiredoxin-1. Onco Targets Ther 14:3599–609.
   PubMed Web of Science ®Google Scholar
• Zhang T, Xiong H, Ma X, et al. (2021b). Supramolecular tadalafil nanovaccine for cancer immunotherapy by alleviating myeloid-derived suppressor cells and heightening immunogenicity. Small Methods 5:e2100115.
   PubMed Web of Science ®Google Scholar
• Zhang X, Huang J, Yu C, et al. (2020b). Quercetin enhanced paclitaxel therapeutic effects towards PC-3 prostate cancer through ER stress induction and ROS production. Onco Targets Ther 13:513–23.
   PubMed Web of Science ®Google Scholar
• Zhang X, Li L, Liu Q, et al. (2019c). Co-delivery of rose bengal and doxorubicin nanoparticles for combination photodynamic and chemo-therapy. J Biomed Nanotechnol 15:184–95.
   PubMed Web of Science ®Google Scholar
• Zhang X, Pei Z, Chen J, et al. (2016c). Exosomes for immunoregulation and therapeutic intervention in cancer. J Cancer 7:1081–7.
   PubMed Web of Science ®Google Scholar
• Zhang XK, Wang QW, Xu YJ, et al. (2021c). Co-delivery of cisplatin and oleanolic acid by silica nanoparticles-enhanced apoptosis and reverse multidrug resistance in lung cancer. Kaohsiung J Med Sci 37:505–12.
   Web of Science ®Google Scholar
• Zhang Y, Xiao C, Li M, et al. (2013). Co-delivery of 10-hydroxycamptothecin with doxorubicin conjugated prodrugs for enhanced anticancer efficacy. Macromol Biosci 13:584–94.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Yang C, Wang W, et al. (2016d). Co-delivery of doxorubicin and curcumin by pH-sensitive prodrug nanoparticle for combination therapy of cancer. Sci Rep 6:21225.
   PubMed Web of Science ®Google Scholar
• Zhang Z, Xu S, Wang Y, et al. (2018b). Near-infrared triggered co-delivery of doxorubicin and quercetin by using gold nanocages with tetradecanol to maximize anti-tumor effects on MCF-7/ADR cells. J Colloid Interface Sci 509:47–57.
   PubMed Web of Science ®Google Scholar
• Zhao MD, Li JQ, Chen FY, et al. (2019). Co-delivery of curcumin and paclitaxel by "core-shell" targeting amphiphilic copolymer to reverse resistance in the treatment of ovarian cancer. Int J Nanomedicine 14:9453–67.
   PubMed Web of Science ®Google Scholar
• Zhao X, Chen Q, Li Y, et al. (2015a). Doxorubicin and curcumin co-delivery by lipid nanoparticles for enhanced treatment of diethylnitrosamine-induced hepatocellular carcinoma in mice. Eur J Pharm Biopharm 93:27–36.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Cai C, Liu M, et al. (2020a). Drug-binding albumins forming stabilized nanoparticles for co-delivery of paclitaxel and resveratrol: in vitro/in vivo evaluation and binding properties investigation. Int J Biol Macromol 153:873–82.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Chen F, Pan Y, et al. (2015b). Nanodrug formed by coassembly of dual anticancer drugs to inhibit cancer cell drug resistance. ACS Appl Mater Interfaces 7:19295–305.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Huan ML, Liu M, et al. (2016). Doxorubicin and resveratrol co-delivery nanoparticle to overcome doxorubicin resistance. Sci Rep 6:35267.
   PubMed Web of Science ®Google Scholar
• Zhao Y, Wang K, Zheng Y, et al. (2020b). Co-delivery of salinomycin and curcumin for cancer stem cell treatment by inhibition of cell proliferation, cell cycle arrest, and epithelial-mesenchymal transition. Front Chem 8:601649.
   PubMed Web of Science ®Google Scholar
• Zheng D, Zhao J, Li Y, et al. (2021a). Self-assembled pH-sensitive nanoparticles based on Ganoderma lucidum polysaccharide–methotrexate conjugates for the co-delivery of anti-tumor drugs. ACS Biomater Sci Eng 7:3764–73.
   PubMed Web of Science ®Google Scholar
• Zheng S, Wang J, Ding N, et al. (2021b). Prodrug polymeric micelles integrating cancer-associated fibroblasts deactivation and synergistic chemotherapy for gastric cancer. J Nanobiotechnology 19:381.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Wen LM, Li R, et al. (2019). Recent advances of nano-drug delivery system in oral squamous cell carcinoma treatment. Eur Rev Med Pharmacol Sci 23:9445–53.
   PubMed Web of Science ®Google Scholar
• Zou L, Wang D, Hu Y, et al. (2017). Drug resistance reversal in ovarian cancer cells of paclitaxel and borneol combination therapy mediated by PEG-PAMAM nanoparticles. Oncotarget 8:60453–68.
   PubMedGoogle Scholar
• Zucker D, Barenholz Y. (2010). Optimization of vincristine-topotecan combination–paving the way for improved chemotherapy regimens by nanoliposomes. J Control Release 146:326–33.
   PubMed Web of Science ®Google Scholar